This lease termination is a routine cost-reduction step for an already-idle facility. The cash impact (~1.3% of market cap) is manageable. Monitor next quarterly update for cash runway and any update on CDMO partnership terms.
Price Chart
Executive Summary
Tenaya Therapeutics terminated its lease for the former Genetic Medicines Manufacturing Center in Union City, CA, which was already decommissioned in 2025. The company will forfeit a $1.75M security deposit and pay a ~$294K termination fee, eliminating future lease obligations through 2031. Tenaya will transfer manufacturing to a CDMO and cites sufficient TN-201 and TN-401 inventory for ongoing trials.
Key Facts
- Lease termination for ~94,046 sq ft facility at 33498 Central Avenue, Union City, CA, effective August 31, 2026 (original expiry July 2031).
- Company forfeits $1,750,000 security deposit and pays a one-time termination fee of approximately $294,200.
- Facility already decommissioned in 2025 to reduce costs; closure enabled by available inventory of TN-201 and TN-401.
- Tenaya will transfer AAV manufacturing process to a contract development manufacturing organization for late-stage/commercial needs.
- Stock market cap ~$162M; analyst consensus 93% bullish (13 Buy, 1 Hold).
Financial Impact
Immediate cash cost of ~$2.044M ($1.75M forfeited deposit + ~$294K fee); future lease obligations eliminated (original lease through 2031, value not disclosed).
Risk Factors
- Potential supply chain disruption if CDMO transition does not go as planned
- Insufficient manufacturing capacity for late-stage/commercial needs if CDMO ramp-up delayed
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-294879 |
| Document: 0001193125-26-294879-index-headers.html | 0001193125-26-294879 |
| Document: 0001193125-26-294879-index.html | 0001193125-26-294879 |
| Document: 0001193125-26-294879.txt | 0001193125-26-294879 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 2d ago | DEFA14A | $0.3945 | awaiting T+60 | — | $0.4086 (+3.57%) |
Oct 23, 2026 3d ago | DEF 14A | $0.3850 | awaiting T+60 | — | $0.4086 (−6.13%) |
Aug 17, 2026 9w ago | 144 | $0.6990 | awaiting T+60 | — | $0.4086 (+41.55%) |
Jul 2, 2026 16w ago | 8-K | $0.7869 $0.5898 | ▼ −25.05% | ▼ −28.62% | $0.4086 (−48.07%) |
Jun 29, 2026 17w ago | 8-K | $0.7349 $0.6822 | ▼ −7.17% | ▼ −11.56% | $0.4086 (−44.40%) |
Jun 12, 2026 19w ago | Institutional Cluster | $0.7118 $0.6634 | ▲ +6.80% | ▲ +10.06% | $0.4086 (+42.60%) |
May 29, 2026 21w ago | 8-K | $0.8700 $0.7014 | ▼ −19.38% | ▼ −20.61% | $0.4086 (−53.03%) |
May 19, 2026 22w ago | Insider Cluster | $0.8080 $0.7281 | ▼ −9.89% | ▼ −14.89% | $0.4086 (−49.43%) |
Apr 16, 2026 27w ago | DEFA14A | $0.7470 $0.8365 | ▲ +11.98% | ▲ +4.94% | $0.4086 (−45.30%) |
Mar 11, 2026 32w ago | 8-K | $0.8930 $0.7280 | ▼ −18.48% | ▼ −29.17% | $0.4086 (−54.24%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers